11:35 AM - 11:52 AM Industry Satellite Symposium Presentation ROCHE - Immunotherapy: The new standard of care for solid tumours Industry Satellite Symposium
  • S. Dawood

Creating a new treatment algorithm for metastatic triple-negative breast cancer (ID 49)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
11:35 AM - 11:52 AM
Duration
17 Minutes
Location
Hall 404, Singapore, Singapore, Singapore
Date
11/25/2018
Time
11:30 AM - 12:30 PM
Speakers
  • S. Dawood
05:45 PM - 05:50 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Oncology biosimilars in Asia ESMO Colloquium

Conclusions (ID 82)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
05:45 PM - 05:50 PM
Duration
5 Minutes
Location
Hall 404, Singapore, Singapore, Singapore
Date
11/23/2018
Time
04:30 PM - 06:00 PM
01:05 PM - 01:35 PM Industry Satellite Symposium Presentation ASTRAZENECA - DNA Damage response in ovarian and breast cancers: Promising evidence heralds new hope Industry Satellite Symposium
  • J. Ledermann

BRCAm to PSR to first line - Evolution of PARPi in ovarian cancer (ID 8)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
01:05 PM - 01:35 PM
Duration
30 Minutes
Location
Hall 404, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • J. Ledermann
01:15 PM - 01:35 PM Industry Satellite Symposium Presentation IPSEN - Raising the bar in the management of patients with urological cancers Industry Satellite Symposium
  • L. Krieger

Advanced RCC: Current strategies and clinical management after disease progression (ID 40)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
01:15 PM - 01:35 PM
Duration
20 Minutes
Location
Room 311, Singapore, Singapore, Singapore
Date
11/24/2018
Time
12:45 PM - 02:15 PM
Speakers
  • L. Krieger
01:35 PM - 01:50 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Updated therapeutic approach of castration-resistant prostate cancer ESMO Colloquium
  • M. De Santis

Is there an optimal sequencing strategy in mCRPC? (ID 72)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
01:35 PM - 01:50 PM
Duration
15 Minutes
Location
Room 324, Singapore, Singapore, Singapore
Date
11/24/2018
Time
12:45 PM - 02:15 PM
Speakers
  • M. De Santis
02:05 PM - 02:15 PM Industry Satellite Symposium Presentation ASTRAZENECA - Right from the start: Putting evidence into practice in NSCLC Industry Satellite Symposium
  • S. Wong

Q&A and conclusion (ID 31)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
02:05 PM - 02:15 PM
Duration
10 Minutes
Location
Hall 404, Singapore, Singapore, Singapore
Date
11/24/2018
Time
12:45 PM - 02:15 PM
Speakers
  • S. Wong
09:30 AM - 09:40 AM ESMO Colloquium Presentation ESMO COLLOQUIUM - Metastatic gastric and oeso-gastric junction cancers ESMO Colloquium
  • C. Ng

Biomarker driven option in 1st line treatment options (ID 63)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
09:30 AM - 09:40 AM
Duration
10 Minutes
Location
Room 324, Singapore, Singapore, Singapore
Date
11/25/2018
Time
09:15 AM - 10:15 AM
Speakers
  • C. Ng
12:45 PM - 12:50 PM Industry Satellite Symposium Presentation MSD - A pan tumor perspective: Advances of immunotherapy in oncology Industry Satellite Symposium
  • H. Toh

Welcome and introduction (ID 22)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
12:45 PM - 12:50 PM
Duration
5 Minutes
Location
Hall 405, Singapore, Singapore, Singapore
Date
11/24/2018
Time
12:45 PM - 02:15 PM
Speakers
  • H. Toh
11:40 AM - 12:00 PM Industry Satellite Symposium Presentation TAKEDA PHARMACEUTICALS - Evolving advanced ALK+ NSCLC treatment landscape Industry Satellite Symposium
  • S. Peters

Making the difference in first line (ID 54)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
11:40 AM - 12:00 PM
Duration
20 Minutes
Location
Hall 407, Singapore, Singapore, Singapore
Date
11/25/2018
Time
11:30 AM - 12:30 PM
Speakers
  • S. Peters
01:50 PM - 02:10 PM ESMO Colloquium Presentation ESMO COLLOQUIUM - Immunotherapy of lung cancer: Alone or in combination? ESMO Colloquium
  • D. Planchard

What’s new in the guidelines for immune therapy of metastatic NSCLC? (ID 88)

Presentation Topic
ESMO Colloquium Presentation
Lecture Time
01:50 PM - 02:10 PM
Duration
20 Minutes
Location
Room 311, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • D. Planchard
01:05 PM - 01:35 PM Industry Satellite Symposium Presentation PFIZER ONCOLOGY - Making strides in the management of HR+ HER2- metastatic breast cancer Industry Satellite Symposium
  • G. Curigliano

The benefits of CDK4/6 inhibitors for patients with HR+ HER2- mBC (ID 13)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
01:05 PM - 01:35 PM
Duration
30 Minutes
Location
Hall 407, Singapore, Singapore, Singapore
Date
11/23/2018
Time
12:45 PM - 02:15 PM
Speakers
  • G. Curigliano
11:55 AM - 12:15 PM Industry Satellite Symposium Presentation MERCK - What are the treatment options for R/M SCCHN beyond immune check-point inhibitors? Industry Satellite Symposium
  • J. Hsieh

What’s the weapon we can use beyond EXTREME & IO for R/M SCCHN (ID 45)

Presentation Topic
Industry Satellite Symposium Presentation
Lecture Time
11:55 AM - 12:15 PM
Duration
20 Minutes
Location
Hall 405, Singapore, Singapore, Singapore
Date
11/25/2018
Time
11:30 AM - 12:30 PM
Speakers
  • J. Hsieh